Title

Data Protection

Policymakers must remain alert to the challenges and threats to privacy posed by society’s increasing reliance on data. The Charter of Fundamental Rights of the European Union recognises an explicit right to protection of personal data, but the question of what constitutes a justified interference or limitation to this right is not satisfactorily answered, leaving the door open to possible abuses. There is an unacceptable lack of transparency surrounding the existence and activities of mass communications surveillance programs such as PRISM and Tempora, and the EU must lead a more open conversation about the threat to citizens’ rights posed by these programs.
Additionally, although GDPR has in many ways come to represent an international standard for the data privacy of individual users, it maintains a status quo which is arguably no longer serving the best interests of individuals. In particular, new models of individual consent to data processing need to be explored and implemented.

Drugs

LYMEC believes that the repressive model of drugs regulation has failed: in response to criminalization of many drugs, cartel activity has soared, and abuse of prescription drugs is widespread. The EU and its Member States must rethink their attitude towards drugs, and focus more on regulation, harm prevention and rehabilitation, rather than simple prohibition.